Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)NCT06768671MoonLake Immunotherapeutics AGPhase 3Active not recruiting2026-09-28Estimated
A Study of Setmelanotide in Patients With Prader-Willi SyndromeNCT06772597RYTMPhase 2Active not recruiting2026-10-31Estimated
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial CancerNCT06774131URGNPhase 3Recruiting2027-03Estimated
This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third MolarsNCT06774625Latigo BiotherapeuticsPhase 2Completed2025-08-08Actual
A Randomized Study of Azetukalner Versus Placebo in Major Depressive DisorderNCT06775379XENEPhase 3Recruiting2026-08Estimated
Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain MetastasesNCT06777433RADXPhase 2Active not recruiting2026-04-23Actual
A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and HypertensionNCT06785454MLYSPhase 2Completed2025-12-17Actual
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AMLNCT06788756MBRXPhase 2, Phase 3Recruiting2029-08Estimated
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCCNCT06788990Bicara TherapeuticsPhase 2, Phase 3Recruiting2028-04Estimated
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)NCT06789913RLAYPhase 2Recruiting2031-07Estimated
Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaNCT06790966PDSBPhase 3Terminated2026-08-25Actual
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEFNCT06793371CytokineticsPhase 2Recruiting2026-09Estimated
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset SeizuresNCT06798896SUPNPhase 2Recruiting2027-08Estimated
Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia GravisNCT06799247Cartesian TherapeuticsPhase 3Active not recruiting2026-12-30Estimated
A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist UseNCT06804603Vanda PharmaceuticalsPhase 2Completed2025-10-06Actual
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety DisorderNCT06809179VTGNPhase 2Recruiting2026-04Estimated
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)NCT06809595Definium Therapeutics US, Inc.Phase 3Active not recruiting2026-08-13Actual
Long-Term Safety and Efficacy of Plozasiran in Adults With HypertriglyceridemiaNCT06822790Arrowhead PharmaceuticalsPhase 3Recruiting2028-07Estimated
Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular EdemaNCT06825702KPRXPhase 2Recruiting2026-11Estimated
VK2735 for Weight Management Phase 2 (Venture Oral Dosing)NCT06828055VKTXPhase 2Completed2025-06-24Actual
ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective TrialNCT06828861AARDPhase 3Terminated2026-05-07Actual
Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder CancerNCT06829823IBRXPhase 2Not yet recruiting2026-11Estimated
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive DisorderNCT06830044Vanda PharmaceuticalsPhase 3Recruiting2028-03Estimated
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney DiseaseNCT06830629Maze TherapeuticsPhase 2Recruiting2026-09Estimated
Open Label Safety Study of Tradipitant in Idiopathic and Diabetic GastroparesisNCT06836557Vanda PharmaceuticalsPhase 3Recruiting2025-12Estimated
A Study of TYRA-300 in Children With Achondroplasia: BEACH301NCT06842355TYRAPhase 2Recruiting2030-01Estimated
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)NCT06842498Kyntra BioPhase 2Recruiting2028-03-31Estimated
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)NCT06843239Zura Bio IncPhase 2Active not recruiting2027-05Estimated
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic HypersomniaNCT06843590Alkermes, Inc.Phase 2Active not recruiting2026-11Estimated
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque PsoriasisNCT06846541ALMSPhase 3Active not recruiting2028-11Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.